Trial watch: Personalized medicines in late-stage development

Nature Reviews Drug Discovery

Volumn 13, Issue 5, 2014, Pages 324-325

  Milne, Christopher Paul ^a   Garafalo, Steve ^a   Bryan, Crystal ^a   McKiernan, Marie ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG DATABASE; DRUG INDICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG UTILIZATION; INTERNET; MEDICAL INFORMATICS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PUBLICATION; RISK BENEFIT ANALYSIS; SHORT SURVEY;

CLINICAL TRIALS, PHASE II AS TOPIC; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84899660542     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4325     Document Type: Short Survey

References (0)